DUBLIN, Aug. 1, 2018 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that its corporate presentation will
be webcast live at the 38th Annual Canaccord Genuity
Growth Conference on Wednesday, Aug. 8,
2018 at 10:30 a.m. ET
(3:30 p.m. BST) from Boston. The presentation may be accessed under
the Investors tab on www.alkermes.com and will be archived for 14
days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Contact:
Sandra Coombs
Investor Relations
+1 781 609 6377
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg